Mazzetti on hydroxychloroquine: “We make decisions based on what is concluded...

During a press conference, the head of the Ministry of Health, Pilar Mazzetti, indicated that before the use of hydroxychloroquine in people infected with COVID-19, health personnel carry out a screening to detect that they do not have heart problems, since this drug affects that organ.

“Regarding the use of hydroxychlorquine, we make decisions based on what is concluded in the country. The guide says from the beginning that an evaluation of side effects must be carried out and, as all doctors know, the use of hydroxychloroquine implies that the patient does not have a history of arrhythmia and also that an evaluation of the heart rhythm is carried out during administration ”, declared to the media.

Likewise, he emphasized that this is the reason why when the tours are carried out in the different hospitals in the country dedicated to treating COVID-19, the Minsa makes sure that they have electrocardiographs available so that when the patient requires them, they can be used.

On the other hand, he stressed that the drugs that are applied for the treatment of cases with coronavirus will continue to be applied and requested, while the relevant investigations are carried out.

“The acquisition of the drugs continues while the evaluations are done. The countries are independent, each country makes its decision, ”he said.

Finally, he pointed out that the interest of the Ministry of Health is that patients have, as far as possible, the option of receiving some treatment that reduces their viral load.

Coronavirus in Peru, latest news:

COVID-19 Newsletter – The Republic

Subscribe here to the La República newsletter and receive daily in your email all the information about the state of emergency and the COVID-19 pandemic.

Source link by

*The article has been translated based on the content of Source link by
. If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!

These were the details of the news Mazzetti on hydroxychloroquine: “We make decisions based on what is concluded... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at en24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Street clashes in Bangladesh leave 702 people injured, among them 104 police and 30 journalists
NEXT US military raises alert level for Europe bases: reports